Santuário Folho Crítica 1r41hl12952401 rsk3 anchoring disruptor therapy for heart failure nih reporter Artesão Desconexão Bem
Reprieve Cardiovascular Announces Late-Breaking Acute Heart Failure Clinical Trial Data | Technology Networks
Frontiers | Device-based therapy for decompensated heart failure: An updated review of devices in development based on the DRI2P2S classification
Heart Failure in the Era of Precision Medicine: A Scientific Statement From the American Heart Association | Circulation: Genomic and Precision Medicine
Cancers | Free Full-Text | Harnessing RKIP to Combat Heart Disease and Cancer
Sensors | Free Full-Text | Feasibility and First Results of Heart Failure Monitoring Using the Wearable Cardioverter–Defibrillator in Newly Diagnosed Heart Failure with Reduced Ejection Fraction
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure - Ponikowski - 2016 - European Journal of Heart Failure - Wiley Online Library
Emerging roles of A-kinase anchoring proteins in cardiovascular pathophysiology - ScienceDirect
Cardiomyocyte-specific disruption of soluble epoxide hydrolase limits inflammation to preserve cardiac function | American Journal of Physiology- Heart and Circulatory Physiology
Efficacy of Pharmacologic and Cardiac Implantable Electronic Device Therapies in Patients With Heart Failure and Reduced Ejection Fraction | Circulation: Arrhythmia and Electrophysiology
Santuário Folho Crítica 1r41hl12952401 rsk3 anchoring disruptor therapy for heart failure nih reporter Artesão Desconexão Bem
Cardiac fibroblasts regulate the development of heart failure via Htra3-TGF-β-IGFBP7 axis | Nature Communications
Santuário Folho Crítica 1r41hl12952401 rsk3 anchoring disruptor therapy for heart failure nih reporter Artesão Desconexão Bem
Santuário Folho Crítica 1r41hl12952401 rsk3 anchoring disruptor therapy for heart failure nih reporter Artesão Desconexão Bem
Tiny Device Is a 'Huge Advance' for Treatment of Severe Heart Failure - The New York Times
Precision medicine for heart failure based on molecular mechanisms: The 2019 ISHR Research Achievement Award Lecture - ScienceDirect
APP Webinar (Full Length): BAT - A Novel Approach to Class II/III Heart Failure Management - YouTube
Will introduction of ARNI reduce the need of device therapy in heart failure with reduced ejection fraction? | The Egyptian Heart Journal | Full Text
Heart Failure - A practical approach presented by the CardioNerds
Santuário Folho Crítica 1r41hl12952401 rsk3 anchoring disruptor therapy for heart failure nih reporter Artesão Desconexão Bem
Heart Failure Strategically Focused Research Network: Summary of Results and Future Directions | Journal of the American Heart Association
Santuário Folho Crítica 1r41hl12952401 rsk3 anchoring disruptor therapy for heart failure nih reporter Artesão Desconexão Bem
Santuário Folho Crítica 1r41hl12952401 rsk3 anchoring disruptor therapy for heart failure nih reporter Artesão Desconexão Bem
Santuário Folho Crítica 1r41hl12952401 rsk3 anchoring disruptor therapy for heart failure nih reporter Artesão Desconexão Bem
